Drug Use Mediates the Relationship Between Depressive Symptoms and Adherence to ART Among Recently Incarcerated People Living With HIV
Affiliations
- PMID: 30535731
- PMCID: PMC6555693
- DOI: 10.1007/s10461-018-2355-3
Abstract
Depression is a known risk factor for antiretroviral therapy (ART) non-adherence, but little is known about the mechanisms explaining this relationship. Identifying these mechanisms among people living with HIV (PLHIV) after release from prison is particularly important, as individuals during this critical period are at high risk for both depression and poor ART adherence. 347 PLHIV recently released from prison in North Carolina and Texas were included in analyses to assess mediation of the relationship between depressive symptoms at 2 weeks post-release and ART adherence (assessed by unannounced telephone pill counts) at weeks 9-21 post-release by the hypothesized explanatory mechanisms of alcohol use, drug use, adherence self-efficacy, and adherence motivation (measured at weeks 6 and 14 post-release). Indirect effects were estimated using structural equation models with maximum likelihood estimation and bootstrapped confidence intervals. On average, participants achieved 79% ART adherence. The indirect effect of depression on adherence through drug use was statistically significant; greater symptoms of depression were associated with greater drug use, which was in turn associated with lower adherence. Lower adherence self-efficacy was associated with depressive symptoms, but not with adherence. Depression screening and targeted mental health and substance use services for depressed individuals at risk of substance use constitute important steps to promote adherence to ART after prison release.
Keywords: Adherence; Antiretroviral therapy; Depression; Drug use; Incarceration; Mediation.
Conflict of interest statement
Conflict of interest:
The authors declare that they have no conflicts of interest.
Similar articles
- Association of Depressive Symptoms With Lapses in Antiretroviral Medication Adherence Among People Living With HIV: A Test of an Indirect PathwayJD Babowitch et al. AIDS Behav 22 (10), 3166-3174. PMID 29572762.Viral suppression, a critical component of HIV care, is more likely when individuals initiate antiretroviral therapy (ART) early in disease progression and maintain optim …
- Antiretroviral Adherence Following Prison Release in a Randomized Trial of the imPACT Intervention to Maintain Suppression of HIV ViremiaBL DiPrete et al. AIDS Behav 23 (9), 2386-2395. PMID 30963321. - Randomized Controlled TrialMany people living with HIV (PLWH) pass through correctional facilities each year, a large proportion of whom do not maintain viral suppression following release. We exam …
- Antiretroviral Therapy Adherence and Self-Efficacy Among People Living With HIV and a History of Drug Use in VietnamL Li et al. Int J STD AIDS 28 (12), 1247-1254. PMID 28632477.People living with HIV with a history of drug use face additional psychosocial challenges that could compromise their adherence to antiretroviral therapy (ART). This stud …
- Depression and Adherence to Antiretroviral Therapy in Low-, Middle- And High-Income Countries: A Systematic Review and Meta-AnalysisOA Uthman et al. Curr HIV/AIDS Rep 11 (3), 291-307. PMID 25038748. - ReviewWe investigated the associations between depressive symptoms and adherence to antiretroviral therapy (ART) among people living with HIV (PLHIV). We searched the PubMed, E …
- Depression, Alcohol Use and Adherence to Antiretroviral Therapy in sub-Saharan Africa: A Systematic ReviewE Nakimuli-Mpungu et al. AIDS Behav 16 (8), 2101-18. PMID 22116638. - ReviewThis study evaluated estimates of depression symptoms, major depression, alcohol use or disorders and their association with ART adherence in sub-Saharan Africa. Studies …
No hay comentarios:
Publicar un comentario